Double- and Single-Lung Transplantation: An Analysis of Twenty Years of OPTN/UNOS Registry Data
|
|
- Lenard Powers
- 6 years ago
- Views:
Transcription
1 1 CHAPTER 1 Double- and Single-Lung Transplantation: An Analysis of Twenty Years of OPT/UOS Registry Data Junchao Cai Terasaki Foundation Laboratory, Los Angeles, CA, USA The number of lung transplants steadily increased in the United States within past 2 decades. The annual numbers of lung transplants exceeded 1,4 in 25 and 26. The percentage of patients, who experienced acute rejection within the first posttransplant year, significantly dropped from more than 9% during the199s to less than 4% in recent years. Short- and long-term graft survival rates for both double- and single-lung transplants significantly improved in recent years. PATIETS AD METHODS Between 1/1/1987 and -11/2/27, 7,962 double-lung transplants, 4,325 left-lung transplants, and 4,114 right-lung transplants were reported to the UOS registry ( Statistical analyses presented in this chapter include the entire cohort of double- and single-lung transplant recipients. Survival rates were calculated using Kaplan-Meier methods. Statistical significance was determined by the log-rank test for comparison of survival curves. Waiting List According to the UOS national data reports, as of January 4, 28, 2,237 patients were on the waiting list. Among them, 1,16 patients were in the 5-64 age group and 53 patients were in age group (Figure 1). When all the waiting patients are grouped by their original diseases, COPD, IPF, CF, PPH, ATD and Sarcoidosis were the top 6 major diseases which represented 78% of patients (Figure 2). Figure 1. Current US lung transplant waiting list by patient age. OPT/UOS LUG REGISTRY RESULTS Major Lung Transplant Centers As of October 31, 27, a total of 11 US transplant centers reported at least one lung transplant, while 17 US centers performed living donor singlelung transplants (Table 1). About 76% of deceased donor lung transplants were performed by the top 3 centers; while more than 5% of living donor lung transplants were performed in 2 Los Angeles hospitals. umber of patients COPD IPF CF PPH ATD Sarcoidosis Others Figure 2. Current US lung transplant waiting list by patient original diseases. Clinical Transplants 27, Terasaki Foundation Laboratory, Los Angeles, California
2 2 CAI Table 1. Major lung transplant centers in the US. Rank Centers Donor Type Percent Percent (accumulated) Largest Deceased Donor Lung Transplant Centers Deceased all centers (11) 16,13 1 PAPT-TX1 Univ of Pittsburgh Med Ctr MOBH-TX1 Barnes-Jewish Hospital CDU-TX1 Duke University Medical Center OHCC-TX1 Cleveland Clinic Foundation MUM-TX1 Univ. of Minnesota Medical Center PAUP-TX1 The Hosp of the Univ of PA ILLU-TX1 Loyola Univ Med Center YCP-TX1 The Presbyterian Hosp in Y City ALUA-TX1 Univ of Alabama Hospital WAUW-TX1 Univ of Washington Med Ctr IIM-TX1 Clarian Health-Methodist/IU/Riley COUC-TX1 University of Colorado Hospital/HSC MIUM-TX1 Univ of Michigan Med Ctr CAUC-TX1 UCLA Medical Center FLUF-TX1 Shands Hosp at Univ of Fl WIUW-TX1 Univ of Wisconsin Hosp and Clinics VAUV-TX1 Univ of Virginia HSC CASD-TX1 UCSD Medical Center TXMH-TX1 The Methodist Hospital CASU-TX1 Stanford Univ Med Ctr CMH-TX1 UC Hospitals TXBC-TX1 University of Texas Health Science Center MAPB-TX1 Brigham and Womens Hosp MOCH-TX1 St. Louis Childrens Hospital CASF-TX1 Univ of CA San Francisco Med Ctr CAUH-TX1 USC University Hospital TVU-TX1 Vanderbilt Univ Med Ctr VAFH-TX1 Inova Fairfax Hosp TXTX-TX1 Baylor University Medical Center GAEM-TX1 Emory Univ Hospital ALL 17 Living Donor Lung Transplant Centers Living all 17 centers CAUH-TX1 USC University Hospital CACL-TX1 Childrens Hospital Los Angeles MOCH-TX1 St. Louis Childrens Hospital MAMG-TX1 Massachusetts General Hospital MUM-TX1 Univ. of Minnesota Medical Center CMH-TX1 UC Hospitals CDU-TX1 Duke University Medical Center PAPT-TX1 Univ of Pittsburgh Med Ctr CASD-TX1 UCSD Medical Center VAUV-TX1 Univ of Virginia HSC CASU-TX1 Stanford Univ Med Ctr PACP-TX1 Childrens Hosp of Philadelphia MAPB-TX1 Brigham and Womens Hosp MDJH-TX1 Johns Hopkins Hospital PACH-TX1 Childrens Hospital of Pittsburgh MACH-TX1 Childrens Hospital Boston TLB-TX1 Le Bonheur Childrens Med Ctr During the time period of 1/1/1988~1/31/27, a total of 16,378 lung transplants (16,13 deceased donor, 248 living donor) were performed in 12 US trasplant centers. About 76% of deceased donor lung transplantation were performed by the top 3 centers; while more than 5% of living donor lung transplantation were performed in two hospitals in Los Angeles.
3 3 Table 2. Major indications for lung transplantation in the US. Double Left Right Indications % Indications % Indications % CF 2, COPD 2, COPD 2, COPD 1, IPF 1, IPF IPF 1, ATD ATD PPH Other, Specify PPH ATD CF CF Bronchiectasis PF-Others Sarcoidosis Sarcoidosis Sarcoidosis Other, Specify Other, Specify PPH PF-Others PF-Others GF-OB GF-OB GF-OB LAM 23.5 ES(ASD) 28.7 CF=Cystic fibrosis; COPD=COPD/Emphysema; IPF=Idiopathic pulmonary fibrosis; PPH=Primary pulmonary hypertension; ATD=Alpha antitrypsin deficiency; PF-Others=Pulmonary fibrosis-other specify cause; GF-OB=Lung retransplant/graft Failure: Obliterative bronchiolitis; LAM=Lymphangioleiomyomatosis; ES(ASD)=Eisenmenger s syn: atrial septal defect Major Indications for Lung Transplantation The major indications for double- and single- (left or right) lung transplants differed in their rank order (Table 2). For double-lung transplants, CF (3.1%), COPD (21.4%), and IPF (13%) were the top 3 indications; while for single lung transplantation, COPD (46.3% L, 52.7% R), IPF (28.1% L, 2.8% R) and ATD (7.6% L, 8.% R) were the 3 major indications. It is notable, that patients with an original diagnosis of COPD alone accounts for almost 5% of all single-lung transplant recipients. Annual Case umbers The annual numbers of lung transplants, and especially double-lung transplants, steadily increased during the past 2 decades (Figure 3). In 1993, the number of double-lung (D) transplants first exceeded the number of either left- (L) or right (R)-lung transplants. Since 22, the annual number of double-lung transplants has exceeded the sum of left- and right-lung transplants. The annual increase in lung transplants was mainly due to the increase in double-lung transplants. OPT/UOS LUG REGISTRY Figure 3. Annual trends in US lung transplantation.
4 4 CAI A Graft survival (%) Double 7,74 Left 4,185 Right 3,971 p<.1 B p=.3473 Figure 4. A. Ten-year graft survival among primary lung transplant recipients. B. Ten-year graft survival among repeat lung transplant recipients. Overall Graft Survival Rates When the entire cohort of lung transplant patients was included in the analysis of first transplant recipients, graft survival rates differed significantly between double- and single-lung transplant recipients and also between right- and left-lung transplant recipients (right>left, p<.1) (Figure 4A). However these differences were not significant among regrafted patients (Figure 4B). Graft survival (%) Double , , ,549 p< Left 1,87 1,177 1,799 p< Years Posttrantplant Right 1,77 1,129 1,661 p< Figure 5. Three-year graft survival for double lung, left lung, and right lung recipients by transplant era. Graft Survival Rates by Eras To analyze the transplant year effect on graft survival, lung transplant recipients were grouped based on their year of transplantation: , , and Three-year graft survival analysis demonstrated that patients who received either double- or single-lung transplants during the most recent era had better graft survival rates than those who were transplanted in earlier eras. The improvement of long-term graft survival seems mainly due to improved one-year survival, more precisely, due to the decreased graft failure
5 5 Graft survival (%) HLA MM -3 1, , ,173 Double 6 1,234 p= ,148 Left 676 p= ,141 Right 69 p=.2772 Figure 6. Ten-year graft survival among double lung, left lung, and right lung transplant recipients by HLA mismatch. rate within the first 2-3 months (Figure 5). Graft Survival and HLA Mismatches The average HLA mismatch level was 4.5±1.1 for all lung transplant recipients, and there was no difference between different types of lung transplantation (data not shown). To see the effect of HLA mismatch on long-term graft survival, lung transplant recipients were grouped based on HLA-mismatch levels: -3, 4, 5 and 6 mismatches. Figure 6 shows a negative association between HLA mismatch and 1-year graft survival and this negative effect of mismatch on graft survival is statistically significant in both double- and left-lung transplants. Graft Survival and First Year Rejection Episodes As shown in Figure 7, before 1997 more than 8% of lung transplant recipients reportedly had drug-treated rejection during the first posttransplant year. The first year rejection rates significantly decreased to less than 7% in 1998 and continued to drop over the past 1 years. It is clear that, for either double- or single-lung transplant recipients, patients who experienced drug-treated rejection with the first posttransplant year had significantly poorer long-term graft survival compared to those without rejection (Figure 8). Graft Survival and Recipient Original Diseases OPT/UOS LUG REGISTRY Figure 7. Annual incidence of treated rejection within the first posttransplant year. As we reported in 26, the top 5 diseases leading to lung transplantation included COPD, IPF, CF, ATD, and PPH (1). Graft survival rates for double-, left- and right-lung transplant recipients were compared in different cohorts grouped by original diseases. As shown in Figure 9, except for CF patients with mostly living donor single-lung transplants, double-lung transplant recipients almost always had better survival than those with either left- or right-lung transplants. For COPD, ATD, and PPH patients, rightlung transplants had a significantly higher graft survival rate than left-lung transplants. However, left-lung transplants had better survival rates than right-lung transplants among CF patients. Among IPF and other original diseases patients, there was no significant difference between left- and right-lung transplants.
6 6 CAI Graft survival (%) Rejection o 2,37 Yes Double 1,663 p< Left 977 p=.42 Years Posttrantplant 787 Right 953 p=.13 Figure 8. Ten-year graft survival among double lung, left lung, and right lung transplant recipients by first year treated rejection. Graft Survival (%) Graft Survival (%) COPD Double 1,697 Left 1,996 Right 2,158 p<.1 ATD Double 531 Left 329 Right 327 p<.1 Double 1,32 Left 1,211 Right 849 p= PPH Double 538 Left 81 Right 144 IPF p=.469 Double 2,394 Left 18 Right 99 CF p=.138 Double 1,517 Left 462 Right 396 others p=.166 Figure 9. Ten-year graft survival among lung transplant recipients by original disease.
7 7 Figure 1. Ten-year graft survival among female lung transplant recipients by original disease. Interestingly, when recipients were further subgrouped by patient gender, the survival differences between left- and right-lung transplants seemed to be gender related. Among female single-lung recipients (Figure 1), right-lung transplants had higher graft survival than left-lung for COPD, ATD, and other diseases; while for IPF, CF, and PPH patients, the differences were not significant. Among male single-lung recipients (Figure 11), CF patients had better graft survival when they received a left lung; while PPH patients had higher graft survival when they received a right lung. There was no statistically significant difference between left and right lung transplantation for male recipients when their original diseases were COPD, IPF, ATD, or others. OPT/UOS LUG REGISTRY
8 8 CAI Graft Survival (%) Graft Survival (%) CF Double 1,258 Left 36 Right 37 p=.71 IPF Double 668 Left 786 Right 573 p=.6643 PPH Double 165 Left 24 Right 41 p=.33 ATD Double 341 Left 175 Right 21 p=.4363 Double 882 Left 99 Right 954 p=.489 Double 69 Left 191 Right COPD others 166 p=.272 Figure 11. Ten-year graft survival among male lung transplant recipients by original disease. SUMMARY 1. Within the past 2 decades, the annual number of lung transplants, especially double-lung transplants, has steadily increased every year and exceeded 1,4 in the last 2 years. 2. Overall 1-, 5-, and 1-year graft survival rates for double-lung transplant recipients were 79.5%, 5.6%, and 3.4% respectively; those for left-lung transplant recipients were 76.%, 41.8%, and 17.1%; and for right-lung transplant recipients were 78.3%, 44.8%, and 19.2%. 3. The improvement in long-term graft survival in the most recent transplant era was mainly due to improved one-year survival, more precisely, due to the increased early outcome within the first 2-3 months after transplantation. 4. A negative association between HLA mismatch and graft survival is statistically significant in both double and left-lung transplants. 5. Female COPD and ATD single-lung recipients had high long-term graft survival when they received right-lung transplants. While for male single-lung recipients, CF patients had better graft survival when they received left lung transplants; but PPH patients had higher graft survival when receiving right-lung transplants. This association between recipient gender and/or different original diseases and graft survival requires further investigation. 1. Cai J, Mao Q, Ozawa M, Terasaki PI. Lung transplantation in the United States In: Cecka JM, Terasaki PI, Eds. Clinical Transplants 25. Los Angeles, UCLA Immunogenetics Center 25; REFERECES
LUNG ALLOCATION SCORE SYSTEM UPDATE
LUNG ALLOCATION SCORE SYSTEM UPDATE Current Lung Allocation System System was implemented on May 4, 25 The Lung Allocation Score (LAS) is based on a combination of Expected survival in next year without
More informationLung Transplantation A look Inside A Surgeon s Perspective
Lung Transplantation A look Inside A Surgeon s Perspective Hassan Nemeh, MD Henry Ford Hospital Michigan Society of Respiratory Care Spring Conference 2016 Historical background Alexis Carrel 1905 Reported
More informationHealth Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin. The WHI Investigators
Health Risks and Benefits 3 Years After Stopping Randomized Treatment With Estrogen and Progestin The WHI Investigators 1 Background: WHI Hormone Program Design YES N= 10,739 Conjugated equine estrogen
More informationLung Transplantation in the United States,
American Journal of Transplantation 2009; 9 (Part 2): 942 958 Wiley Periodicals Inc. No claim to original US government works Journal compilation C 2009 The American Society of Transplantation and the
More informationQuarterly Statistical Report
01/04/2008 Page 1 of 26 INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report Implant dates: March 1, 2006 November 30, 2007 January 4, 2008 Prepared
More informationPedimacs. Quarterly Statistical Report. Pediatric Registry for Mechanically Assisted Circulatory Support
1 #HHSN268201100025C Alfred M 14 69 112.5 Pedimacs Pediatric Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2017 2nd Quarter Implant and event dates: September 19,
More informationAlfred M Pediatric Registry for Mechanically Assisted Circulatory Support
1 #HHSN268201100025C Alfred M 14 69 112.5 Pedimacs Pediatric Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2017 3rd Quarter Implant and event dates: September 19,
More informationSingle-lung transplantation in the setting of aborted bilateral lung transplantation
Washington University School of Medicine Digital Commons@Becker Open Access Publications 2011 Single-lung transplantation in the setting of aborted bilateral lung transplantation Varun Puri Tracey Guthrie
More informationLung Transplantation: Overview and the MUSC Program
Lung Transplantation: Overview and the MUSC Program Timothy P.M. Whelan MD Associate Professor of Medicine Medical Director of Lung Transplantation History of Lung Transplant James Hardy Univ of Mississippi
More informationWe have no disclosures
Pulmonary Artery Pressure Changes Differentially Effect Survival in Lung Transplant Patients with COPD and Pulmonary Hypertension: An Analysis of the UNOS Registry Kathryn L. O Keefe MD, Ahmet Kilic MD,
More informationLiver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995
Liver Transplantation for Alcoholic Liver Disease in the United States: 1988 to 1995 Steven H. Belle, Kimberly C. Beringer, and Katherine M. Detre T he Scientific Liver Transplant Registry (LTR) was established
More informationEvolution of Surgical Therapies for End-Stage Cardiopulmonary Failure. Heart Failure at the Shoe XI October 5, 2012
Evolution of Surgical Therapies for End-Stage Cardiopulmonary Failure Heart Failure at the Shoe XI October 5, 2012 Robert S.D. Higgins, MD, MSHA Executive Director, Comprehensive Transplant Center Evolution
More informationState Cd. PG1 Inst Name. Madigan Army Med Ctr
Specialty Inst City Inst City Specialty Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology Anesthesiology/ UC San Francisco-CA Critical Care FRANCISCO CA C Walter
More informationRepeat Organ Transplantation in the United States,
American Journal of Transplantation 2007; 7 (Part 2): 1424 1433 Blackwell Munksgaard No claim to original US government works Journal compilation C 2007 The American Society of Transplantation and the
More informationRegistry to Evaluate Early and Long-Term PAH Disease Management. Transforming PAH Experience Into Knowledge
Registry to Evaluate Early and Long-Term PAH Disease Management Transforming PAH Experience Into Knowledge Protocol and Goals of the REVEAL Registry Robyn J. Barst, MD REVEAL Study Objectives To characterize
More informationC/PG2 Specialty Desc. C/PG2 Inst Name. Emory Univ SOM-GA. Child Neurology. Massachuset ts Gen Hosp North Shore Med Ctr/Salem Hosp-MA Orange Park
Inst City e e Emory Univ SOM-GA Anesthesiology ATLANTA GA A Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology UC San Francisco-CA Anesthesiology SAN
More informationChapter 6: Transplantation
Chapter 6: Transplantation Introduction During calendar year 2012, 17,305 kidney transplants, including kidney-alone and kidney plus at least one additional organ, were performed in the United States.
More informationNo Other Company Discloses Higher Transplant Survival Rate. Infusions For Emerging Treatments. Date of Use. Recipient Age (yrs)
Units Used In Transplants/Infusions No Other Company Discloses Higher Transplant Survival Rate Family Banking Provides Exclusive Access To Emerging Treatments With Your Own Cells 175 85% Type 1 Diabetes
More informationDisclosures. Dr. Hall is a paid consultant to the American College of Surgeons (ACS) as Associate Director of ACS-NSQIP
Does Routine Drainage of the Operative Bed following Elective Distal Pancreatectomy reduce Complications? An Analysis of the ACS-NSQIP Pancreatectomy Demonstration Project Stephen W. Behrman, MD 1, Ben
More informationGlobal Outcomes in Pediatric Liver Transplantation
Global Outcomes in Pediatric Liver Transplantation Vicky Lee Ng, MD FRCPC The Hospital for Sick Children, University of Toronto Seattle Children s Hospital: Pediatric Liver Transplant Family Education
More informationProgr am Code Specialty. Preliminary Institution. Emory Univ SOM-GA. Child Neurology
City State Emory Univ SOM-GA Anesthesiology ATLANTA GA A Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology Ctr- Anesthesiology BOSTON C Anesthesiology UC San Francisco-CA Anesthesiology SAN FRANCISCO
More informationChapter Two Incidence & prevalence
Chapter Two Incidence & prevalence Science is the observation of things possible, whether present or past. Prescience is the knowledge of things which may come to pass, though but slowly. LEONARDO da Vinci
More informationJ Am Soc Nephrol 14: , 2003
J Am Soc Nephrol 14: 208 213, 2003 Kidney Allograft and Patient Survival in Type I Diabetic Recipients of Cadaveric Kidney Alone Versus Simultaneous Pancreas/Kidney Transplants: A Multivariate Analysis
More informationVersion 3.0, March 2015
NACC Uniform Set Element Dictionary For the Milestones Form sion 3.0, March 2015 Copyright 2015 University of Washington. Created and published by the ADC Clinical Task Force (John C. Morris, MD, Chair)
More informationA Survey of Anti-fungal Management in Lung Transplantation
TRANSPLANTATION INFECTION A Survey of Anti-fungal Management in Lung Transplantation J. Stephen Dummer, MD, a,d Nikoloz Lazariashvilli, MD, a Jean Barnes, RN, ASN, d Mathew Ninan, MD, c,d and Aaron P.
More informationPressure to expand the donor pool has affected all
Effect of Donor Age and Ischemic Time on Intermediate Survival and Morbidity After Lung Transplantation* Dan M. Meyer, MD; Leah E. Bennett, PhD; Richard J. Novick, MD; and Jeffrey D. Hosenpud, MD Background:
More informationLearning Objectives 3/6/2017
Prevention of Antibody Development Post Transplantation Results from the CTOT-11 Trial () Randall C Starling MD MPH FACC FAHA FESC FHFSA Professor of Medicine Kaufman Center for Heart Failure Department
More informationShould Pediatric Patients Wait for HLA-DR-Matched Renal Transplants?
American Journal of Transplantation 2008; 8: 2056 2061 Wiley Periodicals Inc. C 2008 The Authors Journal compilation C 2008 The American Society of Transplantation and the American Society of Transplant
More informationTo date, 209 patients in the United States have undergone
FORUM Utilization and Outcomes of Kidney Paired Donation in the United States Dorry L. Segev, Lauren M. Kucirka, Sommer E. Gentry, and Robert A. Montgomery Background. Kidney paired donation (KPD) offers
More informationVolunteering in Oklahoma City, OK
6/17/2010 Oklahoma City Profile - Volunteering in information on volunteering and civic engagement Volunteering in Oklahoma City, OK Statistics for this area were collected within the Oklahoma City Metropolitan
More informationMorbidity and Mortality After Living Kidney Donation, : Survey of United States Transplant Centers
American Journal of Transplantation 2003; 3: 830 834 Copyright # Blackwell Munksgaard 2003 Blackwell Munksgaard ISSN 1600-6135 Morbidity and Mortality After Living Kidney Donation, 1999 2001: Survey of
More informationDistal Pancreatectomy with Celiac Axis Resection: What Are the Added Risks?
Distal Pancreatectomy with Celiac Axis Resection: What Are the Added Risks? Joal D. Beane, MD a, Michael G. House, MD a, Susan C. Pitt, MD c, E. Molly Kilbane a, Bruce L. Hall c, Abishek Parmar d, Taylor.
More informationRegulatory Realities Redefining Benefit of Lung Transplant in the Current Era
Regulatory Realities Redefining Benefit of Lung Transplant in the Current Era Gundeep S Dhillon, MD, MPH Associate Professor of Medicine Medical Director, Lung & Heart-Lung Transplantation Program Stanford
More informationSeventy percent of people who are candidates for allogeneic hematopoietic
274 7th Biennial Symposium on Minorities, the Medically Underserved and Cancer Supplement to Cancer The National Marrow Donor Program Meeting the Needs of the Medically Underserved Dennis L. Confer, M.D.
More informationjournal of medicine The new england
The new england journal of medicine established in 1812 february 5, 2004 vol. 350 no. 6 Effect of Changing the Priority for HLA Matching on the Rates and Outcomes of Kidney Transplantation in Minority
More informationEmbracing the Magic: Increasing Organ Acceptance Rates Through Data Review and Risk Stratification
Embracing the Magic: Increasing Organ Acceptance Rates Through Data Review and Risk Stratification Presented by: Sandy Felty, RN, MSN, MHA Lynette Martin del Campo, RN, MSN, FNP-C Sharon Norfles, RN, BSN
More informationThe Regulatory Alphabet: CMS, OPTN, HRSA, SRTR, UNOS And Monitoring of Transplant Outcomes
The Regulatory Alphabet: CMS, OPTN, HRSA, SRTR, UNOS And Monitoring of Transplant Outcomes John Paul Roberts M.D. University of California San Francisco NONE Disclosures Outcome Monitoring Outcome monitoring
More informationNational & International Lectures
2005-2008 National & International Lectures 6/24/05 ECFS Crete, Greece Mucoid Psuedomonas aeruginosa Infection, Antibiotic Resistance, and Lung Disease Progression in Children with Cystic Fibrosis 9/30/05
More informationAccess and Outcomes Among Minority Transplant Patients, , with a Focus on Determinants of Kidney Graft Survival
American Journal of Transplantation 2010; 10 (Part 2): 1090 1107 Wiley Periodicals Inc. Special Feature No claim to original US government works Journal compilation C 2010 The American Society of Transplantation
More informationDebate: HLA matching matters in children
Annual Congress 2018 14 th to 16 th March, the Brighton Centre, Brighton Debate: HLA matching matters in children Presenting the case for - Dr Jon Jin (JJ) Kim, Nottingham Richard & Ronald Herrick 23 Dec
More informationThe Heart Institute Tenth Anniversary Update. October 23, 2017
The Heart Institute Tenth Anniversary Update October 23, 2017 Organizational Structure Medicine Surgery Imaging Anesthesiology Pediatrics Basic Biomedical Sciences BEFORE AFTER * Services provided by contract
More informationTIMING FOR TRANSPLANT: ARE WE ALWAYS LATE?
SCDU CARDIOCHIRURGIA Università degli Studi di Torino Città della Salute e della Scienza Direttore: Prof. Mauro Rinaldi TIMING FOR TRANSPLANT: ARE WE ALWAYS LATE? Mauro Rinaldi LUNG TRANSPLANTATION Transplantation
More informationAnnual Statistics on Organ Replacement in Canada
CIHI Snapshot December 2017 Annual Statistics on Organ Replacement in Canada Dialysis, Transplantation and Donation, 2007 to 2016 This summary document provides key findings from the latest annual statistics
More informationLong-Term Renal Allograft Survival in the United States: A Critical Reappraisal
American Journal of Transplantation 2011; 11: 450 462 Wiley Periodicals Inc. C 2010 The Authors Journal compilation C 2010 The American Society of Transplantation and the American Society of Transplant
More informationDevelopment of the New Lung Allocation System in the United States
American Journal of Transplantation 2006; 6 (Part 2): 1212 1227 Blackwell Munksgaard No claim to original US government works Journal compilation C 2006 The American Society of Transplantation and the
More informationUCLA Kidney Exchange. An option for patients with incompatible living donors
UCLA Kidney Exchange An option for patients with incompatible living donors What is a kidney exchange? A kidney exchange is an innovative twist on efforts aimed at increasing the donor pool by giving people
More informationIN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT PATIENTS WITH BRINCIDOFOVIR: FINAL 36 WEEK RESULTS FROM THE ADVISE TRIAL
TREATMENT OF ADENOVIRUS (AdV) INFECTION IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT PATIENTS WITH BRINCIDOFOVIR: FINAL 36 WEEK RESULTS FROM THE ADVISE TRIAL Vinod K. Prasad, MD, FRCP 1, Genovefa A. Papanicolaou,
More informationPredictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
Pediatr Transplantation 2013: 17: 436 440 2013 John Wiley & Sons A/S. Pediatric Transplantation DOI: 10.1111/petr.12095 Predictors of cardiac allograft vasculopathy in pediatric heart transplant recipients
More informationKathryn L. O Keefe, 1 Ahmet Kilic, 1 Amy Pope-Harman, 2 Don Hayes, Jr., 2,3 Stephen Kirkby, 2,3 Robert S. D. Higgins, 1 Bryan A. Whitson 1.
ArtIcle Changes in Pulmonary Artery Pressure Affect Survival Differently in Lung Transplant Recipients Who Have Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease Kathryn L. O Keefe, 1 Ahmet
More informationThe 1-year survival rate approaches 80% for patients
Lung Transplantation for Respiratory Failure Resulting From Systemic Disease Frank A. Pigula, MD, Bartley P. Griffith, MD, Marco A. Zenati, MD, James H. Dauber, MD, Samuel A. Yousem, MD, and Robert J.
More informationSteroid Minimization: Great Idea or Silly Move?
Steroid Minimization: Great Idea or Silly Move? Disclosures I have financial relationship(s) within the last 12 months relevant to my presentation with: Astellas Grants ** Bristol Myers Squibb Grants,
More informationNHS BLOOD AND TRANSPLANT BOWEL ADVISORY GROUP PATIENT SURVIVAL AFTER INTESTINAL TRANSPLANT
INTRODUCTION NHS BLOOD AND TRANSPLANT WEL ADVISORY GROUP PATIENT SURVIVAL AFTER INTESTINAL TRANSPLANT 1 This regular paper reports on patient survival following intestinal transplantation for transplants
More information2014 OREGON STATE FOOTBALL MEDIA GUIDE ALL-TIME SERIES RECORDS ALL-TIME SERIES RECORDS OVERTIME HISTORY. #GoBeavs
ALL-TIME SERIES RECORDS 2014 OREGON STATE FOOTBALL MEDIA GUIDE ALL-TIME SERIES RECORDS OPPONENT TOTAL H A N LAST Akron......................... 1-0 1-0 0-0 0-0 1987 Albany Athletic Club.......... 1-0 1-0
More informationDisclosures. Transplanting Interstitial Lung Disease. Lung Transplantation. Indications. I have nothing to disclose. Adult Lung Transplants
Transplanting Interstitial Lung Disease Steven Hays, MD Associate Professor Medical Director, Lung Transplantation UCSF Medical Center Disclosures I have nothing to disclose Adult Lung Transplants Number
More informationAntibody-Mediated Rejection in the Lung Allograft. Gerald J Berry, MD Dept of Pathology Stanford University Stanford, CA 94305
Antibody-Mediated Rejection in the Lung Allograft Gerald J Berry, MD Dept of Pathology Stanford University Stanford, CA 94305 Gerald J Berry, MD Professor of Pathology Stanford University, Stanford, CA
More informationOverview. Overview. Integrative Oncology: The Catalyst and Bellwether for Integrative Medicine and Health
Integrative Oncology: The Catalyst and Bellwether for Integrative Medicine and Health Margaret A. Chesney, PhD Society for Integrative Oncology Chicago, Illinois November 12, 2017 Overview Overview Describe
More informationSAPIEN 3: Evaluation of a Balloon- Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes
SAPIEN 3: Evaluation of a Balloon- Expandable Transcatheter Aortic Valve in High-Risk and Inoperable Patients With Aortic Stenosis One-Year Outcomes Howard C. Herrmann, MD on behalf of The PARTNER II Trial
More informationIncidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review
Incidence of Rejection in Renal Transplant Surgery in the LVHN Population Leading to Graft Failure: 6 Year Review Jessica Ludolph 1 Lynsey Biondi, MD 1,2 and Michael Moritz, MD 1,2 1 Department of Surgery,
More informationLiving lobar lung transplantation was introduced in 1993 in response. A decade of living lobar lung transplantation: Recipient outcomes GTS
A decade of living lobar lung transplantation: Recipient outcomes Vaughn A. Starnes, MD Michael E. Bowdish, MD Marlyn S. Woo, MD Richard G. Barbers, MD Felicia A. Schenkel, RN Monica V. Horn, RN Renzo
More informationNHS BLOOD AND TRANSPLANT CARDIOTHORACIC ADVISORY GROUP URGENT HEART ALLOCATION SCHEMES 2015/2016 ACTIVITY SUMMARY
INTRODUCTION NHS BLOOD AND TRANSPLANT CARDIOTHORACIC ADVISORY GROUP URGENT HEART ALLOCATION SCHEMES 2015/2016 ACTIVITY SUMMARY 1 This paper is a review of the usage of the Adult Urgent Heart Allocation
More informationOutline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease
Special Considerations for Special Populations: Congenital Heart Disease Valerie Bosco, FNP, EdD Alison Knauth Meadows, MD, PhD University of California San Francisco Adult Congenital Heart Program Outline
More informationLiver and intestine transplantation: summary analysis,
American Journal of Transplantation 25; 5 (Part 2): 916 933 Blackwell Munksgaard Blackwell Munksgaard 25 Liver and intestine transplantation: summary analysis, 1994 23 Douglas W. Hanto a,, Thomas M. Fishbein
More informationCurrent status of kidney and pancreas transplantation in the United States,
American Journal of Transplantation 25; 5 (Part 2): 94 915 Blackwell Munksgaard Blackwell Munksgaard 25 Current status of kidney and pancreas transplantation in the United States, 1994 23 Gabriel M. Danovitch
More informationPostlung Transplant Survival is Equivalent Regardless of Cytomegalovirus Match Status
Postlung Transplant Survival is Equivalent Regardless of Cytomegalovirus Match Status Mark J. Russo, MD, MS, David I. Sternberg, MD, Kimberly N. Hong, MHSA, Robert A. Sorabella, BA, Alan J. Moskowitz,
More informationLung Transplantation for Primary and Secondary Pulmonary Hypertension
Lung Transplantation for Primary and Secondary Pulmonary Hypertension John V. Conte, MD, Marvin J. Borja, BS, Chandrahas B. Patel, BS, Steven C. Yang, MD, Rajiv M. Jhaveri, MD, and Jonathan B. Orens, MD
More informationObjectives 3/6/2017. Impact of Non-HLA Antibodies in Lung Transplantation
Impact of Non-HLA Antibodies in Lung Transplantation Nancy L. Reinsmoen, Ph.D., D(ABHI) Director, HLA and Immunogenetics Laboratory (Retired) Cedars Sinai Medical Center Los Angeles, CA Nancy L. Reinsmoen,
More informationAnalysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation
Cardiac and Pulmonary Replacement Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation Infection and rejection remain the greatest threats to the survival
More informationTrends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Please note, this report is designed for double-sided printing
Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality Please note, this report is designed for double-sided printing American Lung Association Epidemiology and Statistics Unit Research
More informationTRANSPLANTATION OF KIDNEYS FROM DONORS WHOSE HEARTS HAVE STOPPED BEATING TRANSPLANTATION OF KIDNEYS FROM DONORS WHOSE HEARTS HAVE STOPPED BEATING
TRANSPLANTATION OF KIDNEYS FROM DONORS WHOSE HEARTS HAVE STOPPED BEATING YONG W. CHO, PH.D., PAUL I. TERASAKI, PH.D., J. MICHAEL CECKA, PH.D., AND DAVID W. GJERTSON, PH.D. ABSTRACT Background Attempts
More informationMORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS
MORTALITY IN PATIENTS ON DIALYSIS AND TRANSPLANT RECIPIENTS COMPARISON OF MORTALITY IN ALL PATIENTS ON DIALYSIS, PATIENTS ON DIALYSIS AWAITING TRANSPLANTATION, AND RECIPIENTS OF A FIRST CADAVERIC TRANSPLANT
More informationHIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview
HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview Prepared by The Henry J. Kaiser Family Foundation for Southern States Summit
More informationThe New Kidney Allocation Policy: Implications for Your Patients and Your Practice
The New Kidney Allocation Policy: Implications for Your Patients and Your Practice Clinical Practice Today CME Co-provided by Learning Objectives Upon completion, participants should be able to: Explain
More informationRenal Transplant Registry Report 2008
Renal Transplant Registry Report 28 Contents:. Introduction Page 2. Summary of transplant activity 27-28 Page 2 3. Graft and Patient Survival analysis 989-28 Page 3 4. Acute rejection 989-28 Page 24. Comparison
More informationCOMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS
COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS A COMPARISON OF THE SURVIVAL OF SHIPPED AND LOCALLY TRANSPLANTED CADAVERIC RENAL ALLOGRAFTS KEVIN C. MANGE, M.D.,
More informationNAPRTCS Annual Transplant Report
North American Pediatric Renal Trials and Collaborative Studies NAPRTCS 2014 Annual Transplant Report This is a privileged communication not for publication. TABLE OF CONTENTS PAGE II TRANSPLANTATION Section
More informationNACC Uniform Data Set (UDS) DATA ELEMENT DICTIONARY for Follow-up Visit Packet (FVP)
Department of Epidemiology, School of Public Health and Community Medicine, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu
More informationHeart and Lung Transplantation in the United States,
American Journal of Transplantation 2007; 7 (Part 2): 1390 1403 Blackwell Munksgaard No claim to original US government works Journal compilation C 2007 The American Society of Transplantation and the
More informationThoracic organ transplantation
American Journal of Transplantation 24; 4 (Suppl. 9): 93 15 Blackwell Munksgaard Blackwell Munksgaard 24 Thoracic organ transplantation Richard N. Pierson III a,, Mark L. Barr b, Keith P. McCullough c,
More informationKidney Transplantation
Kidney Transplantation Current Kidney Transplantation Department of Surgery Yonsei University Wonju College of Medicine Kim Myoung Soo M.D. ysms91@wonju.yonsei.ac.kr http://gs.yonsei.ac.kr Current Kidney
More informationHeart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017
Heart Transplantation ACC Middle East Conference Dubai UAE October 21, 2017 Randall C Starling MD MPH FACC FAHA FESC FHFSA Professor of Medicine Kaufman Center for Heart Failure Department of Cardiovascular
More informationPNEUMOCONIOSES DIAGNOSIS, DIFFERENTIAL DIAGNOSIS AND TREATMENT. Carlos Robalo Cordeiro
PNEUMOCONIOSES DIAGNOSIS, DIFFERENTIAL DIAGNOSIS AND TREATMENT Carlos Robalo Cordeiro carlos.crobalo@gmail.com Diagnosis 1 History of sufficient exposure to dust, in time and intensity/either occupational
More informationINTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report Centers for Medicare & Medicaid Services 2013 1st Quarter Implant and event dates: June 23, 2006
More informationINTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2012 4th Quarter Implant and event dates: June 23, 2006 to December 31, 2012 Prepared by: The Data
More informationINTERMACS Interagency Registry for Mechanically Assisted Circulatory Support
INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support Quarterly Statistical Report 2013 1st Quarter Implant and event dates: June 23, 2006 to March 31, 2013 Prepared by: The Data
More informationShipping living donor kidneys and transplant recipient outcomes
Received: 8 June 2017 Revised: 20 October 2017 Accepted: 13 November 2017 DOI: 10.1111/ajt.14597 ORIGINAL ARTICLE Shipping living donor kidneys and transplant recipient outcomes Eric Treat 1 Eric K. H.
More informationNACC Uniform Data Set (UDS) DATA ELEMENT DICTIONARY for Telephone Follow-up Packet (TFP)
Department of Epidemiology, School of Public Health, University of Washington 4311 11 th Avenue NE #300 Seattle, WA 98105 phone: (206) 543-8637; fax: (206) 616-5927 e-mail: naccmail@u.washington.edu website:
More informationThe Living Donor Collective: A Scientific Registry for Living Donors
American Journal of Transplantation 2017; 17: 3040 3048 Wiley Periodicals Inc. Personal Viewpoint 2017 The American Society of Transplantation and the American Society of Transplant Surgeons doi: 10.1111/ajt.14365
More informationPancreas After Islet Transplantation: A First Report of the International Pancreas Transplant Registry
American Journal of Transplantation 2016; 16: 688 693 Wiley Periodicals Inc. Brief Communication Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons doi:
More informationType of Program Hospital Program City State. Type of Program Specialty. Specialty Hospital Program City State
Specialty Hospital Program City State Type of Program Hospital Program City State Type of Program Specialty Anesthesiology B I Deaconess Med Ctr- Anesthesiology BOSTON C Brigham & Womens Hosp- Anesthesiology
More informationFAIRNESS/EQUITY UTILITY/EFFICACY EFFICIENCY. The new kidney allocation system (KAS) what has it done? 9/26/2018. Disclosures
The new kidney allocation system (KAS) what has it done? Disclosures No financial disclosure Ryutaro Hirose, MD Professor in Clinical Surgery University of California San Francisco Objectives Describe
More information2014 U.S. organ and tissue transplant cost estimates and discussion
Prepared by: T. Scott Bentley, FSA Principal and Consulting Actuary Peer Reviewed By: Steven G. Hanson, ASA Actuary 2014 U.S. organ and tissue transplant cost estimates and discussion Prepared by: T. Scott
More informationKidney and Pancreas Transplantation in the United States,
American Journal of Transplantation 2006; 6 (Part 2): 1153 1169 Blackwell Munksgaard No claim to original US government works Journal compilation C 2006 The American Society of Transplantation and the
More informationPrevalence and Outcome of Bronchiolitis Obliterans Syndrome After Lung Transplantation
Prevalence and Outcome of Bronchiolitis Obliterans Syndrome After Lung Transplantation Sudhir Sundaresan, MD, Elbert P. Trulock, MD, Thallachallour Mohanakumar, PhD, Joel D. Cooper, MD, G. Alexander Patterson,
More informationChimerix, Inc., Durham, NC; 5 Duke University Medical Center, Durham, NC
Improved Outcomes in Allogeneic Hematopoietic Cell Transplant Patients Treated with Brincidofovir (CMX001, BCV) for Disseminated Adenovirus Disease Compared to Literature: Updated Preliminary Results from
More informationHong Kong Journal Nephrol of 2000;(2): Nephrology 2000;2(2): BR HAWKINS ORIGINAL A R T I C L E A point score system for allocating cadaver
Hong Kong Journal Nephrol of 2000;(2):79-83. Nephrology 2000;2(2):79-83. ORIGINAL A R T I C L E A point score system for allocating cadaveric kidneys for transplantation based on patient age, waiting time
More informationMarta Farrero Torres₁, Marcelo Pando₂, Dolly Tyan₂, Hannah Valantine₃, Spenser Smith₃, Kiran Khush₃
Development of HLA donor specific antibodies after heart transplantation: importance of a new method to detect the first component of the complement cascade Marta Farrero Torres₁, Marcelo Pando₂, Dolly
More informationDoes the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation?
Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan F. Meyers, MD, Tracey J. Guthrie, BSN, Elbert P. Trulock,
More informationchapter seven transplantation page
chapter seven There been times that I thought I couldn t last for long But now I think I m able to carry on It s been a long, a long time coming But I know a change gonna come, oh yes it will Sam Cooke,
More informationThe Acceptable Mismatch program of Eurotransplant.
The Acceptable Mismatch program of Eurotransplant. Frans Claas Leiden University Medical Center Eurotransplant Reference Laboratory Leiden, the Netherlands. Hinterzarten, December 7, 2013 Main problem
More information